Skip to Content
Merck

Skip To

T3077

TRO 19622

≥98% (HPLC), solid

Synonym(s):

Cholest-4-en-3-one, oxime, NSC 21311, Olesoxime

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Size/SKUAvailabilityPrice
5 mg
Please contact Customer Service for Availability
PLN 646.00
PLN 549.10

About This Item

Empirical Formula (Hill Notation):
C27H45NO
CAS Number:
Molecular Weight:
399.65
UNSPSC Code:
12352200
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
solid

PLN 549.10

List PricePLN 646.00Save 15%

Please contact Customer Service for Availability

Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Segment

assay

≥98% (HPLC)

form

solid

color

white

solubility

DMSO: >10 mg/mL

storage temp.

−20°C

InChI

1S/C27H45NO/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28-29)13-15-26(20,4)25(22)14-16-27(23,24)5/h17-19,22-25,29H,6-16H2,1-5H3/b28-21+

InChI key

QNTASHOAVRSLMD-SGWCAAJKSA-N

Application

TRO 19622 has been used as a mitochondrial permeability transition pore inhibitor in mouse neurons2. TRO 19622 is also known to stimulate myelin repair in rat models of demyelination3.

Biochem/physiol Actions

TRO 19622 can decrease axonal degradation and enhance the rescue of motor nerve conduction in peripheral neuropathy. Furthermore, TRO 19622 can reverse neuropathic pain and tactile allodynia in rat models of diabetes and chemotherapy-induced neuropathic pain4.
TRO19622 ia a neuroprotective agent for motor neurons; candidate therapeutic for amyotrophic lateral sclerosis (ALS).

Preparation Note

TRO 19622 is soluble in DMSO at a concentration that is greater than 10 mg/ml.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
SML1648U3633O3139
assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

form

solid

form

powder

form

powder

form

solid

Quality Level

100

Quality Level

100

Quality Level

200

Quality Level

100

storage temp.

−20°C

storage temp.

−20°C

storage temp.

2-8°C

storage temp.

2-8°C

solubility

DMSO: >10 mg/mL

solubility

DMSO: 3 mg/mL, clear (warmed)

solubility

H2O: 10 mg/mL≥

solubility

DMSO: soluble 13 mg/mL

color

white

color

white to beige

color

white to off-white

color

-


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Questions

1–4 of 4 Questions  
  1. What is the solubility of TRO 19622, Product T3077?

    1 answer
    1. This compound is soluble in DMSO (> 10mg/ml).

      Helpful?

  2. What is the Department of Transportation shipping information for this product?

    1 answer
    1. Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.

      Helpful?

  3. What is the structure of TRO 19622, Product T3077?

    1 answer
    1. Please see the following reference for more information: T. Bordet et al., Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J. Pharmacol. Exp. Ther., 322, 709-720 (2007).

      Helpful?

  4. How does TRO 19622, Product T3077 work?

    1 answer
    1. TRO 19622 interacts with the mitochondrial permeability transition pore (mPTP).  By interacting with protein components of the mPTP, it prevents the release of apoptotic factors and therefore protects the neuron.  This mechanism of action may lead to a general neuroprotective activity.  Please see the following reference for more information: T. Bordet et al., Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis J. Pharmacol. Exp. Ther. 322, 709-720, (2007)

      Helpful?

Reviews

No rating value

Active Filters